U.S. Pharmaceutical Sales - Q4 2013

The following is a list of the top 100 prescribed medicines by US National Sales in Q4 2013. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.

Last updated: February 2014 (updated quarterly).

Top 100 drugs for Q4 2013 by units sold

• Sales
• Units* Q4 2013

Rank	Drug	Units (000)
1 (1)	budesonide Generic	12,849	60.65%	Stats
2 (1)	acetaminophen/hydrocodone Generic	9,155	1.25%	Stats
3	ProAir HFA Teva Pharmaceuticals USA, Inc.	7,730	9.86%	Stats
4 ()	ONE TOUCH ULTRA	6,196	n/a	Stats
5 ()	levothyroxine Generic	5,997	n/a	Stats
6 ()	Ventolin HFA GlaxoSmithKline	5,505	n/a	Stats
7 (1)	Nexium AstraZeneca	5,298	-2.75%	Stats
8 (1)	Advair Diskus GlaxoSmithKline	5,263	0.21%	Stats
9 (1)	Lantus Solostar Sanofi	5,059	1.95%	Stats
10 (5)	Cymbalta	4,595	-25.41%	Stats
11 (2)	Lantus Sanofi	4,534	-4.37%	Stats
12 (1)	enoxaparin Generic	4,422	15.55%	Stats
13 (1)	Crestor AstraZeneca	3,656	1.58%	Stats
14	Levemir Novo Nordisk	3,382	0.86%	Stats
15 (1)	metoprolol Generic	3,097	4.77%	Stats
16 (3)	Spiriva Boehringer Ingelheim Pharmaceuticals, Inc.	3,056	-9.61%	Stats
17 (2)	NovoLog FlexPen Novo Nordisk	3,030	1.13%	Stats
18	Humalog Eli Lilly and Company	2,664	1.25%	Stats
19	Novolog Novo Nordisk	2,508	-2.90%	Stats
20 (1)	Abilify Otsuka Pharmaceutical Co., Ltd	2,370	0.47%	Stats
21 (1)	Synthroid AbbVie Inc.	2,286	-4.79%	Stats
22	Januvia Merck	2,168	-2.78%	Stats
23	Nasonex Merck	2,105	-1.41%	Stats
24	Lyrica	2,031	1.10%	Stats
25 (1)	Symbicort AstraZeneca	2,027	7.48%	Stats
26 ()	Tamiflu	1,909	n/a	Stats
27 (2)	Zetia Merck	1,888	-3.33%	Stats
28 (1)	Namenda	1,704	-9.12%	Stats
29 (4)	Flovent HFA GlaxoSmithKline	1,678	7.77%	Stats
30 (2)	Diovan Novartis Pharmaceuticals Corporation	1,661	-3.65%	Stats
31 (2)	Suboxone	1,657	-3.16%	Stats
32 (1)	fenofibrate Generic	1,656	3.18%	Stats
33 (3)	Remicade Janssen Pharmaceuticals, Inc.	1,568	-4.85%	Stats
34 (2)	AndroGel AbbVie Inc.	1,563	-1.76%	Stats
35	Restasis Allergan plc	1,496	3.60%	Stats
36 ()	lidocaine Generic	1,438	n/a	Stats
37 (3)	Dexilant Takeda Pharmaceutical Company Limited	1,420	-2.27%	Stats
38 (2)	Benicar Daiichi Sankyo	1,355	-4.10%	Stats
39 (2)	Lovaza GlaxoSmithKline	1,336	-5.05%	Stats
40 (2)	Xarelto	1,172	15.58%	Stats
41 (2)	Humalog KwikPen Eli Lilly and Company	1,170	3.91%	Stats
42 (2)	OxyContin Purdue Pharma LP	1,048	-1.87%	Stats
43 (2)	VESIcare Astellas Pharma US, Inc.	1,018	0.39%	Stats
44 (1)	Enbrel Amgen Inc.	954	-1.14%	Stats
45	Celebrex	950	1.71%	Stats
46 (3)	Combivent Respimat Boehringer Ingelheim Pharmaceuticals, Inc.	947	11.15%	Stats
47 (3)	Vytorin Merck	888	-7.40%	Stats
48	Cialis Eli Lilly and Company	872	1.99%	Stats
49 (2)	Janumet Merck	865	-3.46%	Stats
50	Pradaxa Boehringer Ingelheim Pharmaceuticals, Inc.	819	-3.53%	Stats
51 (1)	doxycycline Generic	798	2.57%	Stats
52 (1)	methylphenidate Generic	793	10.45%	Stats
53 (2)	Evista	776	-4.55%	Stats
54	Vyvanse Takeda Pharmaceutical Company Limited	775	8.70%	Stats
55	amphetamine/dextroamphetamine Generic	739	5.27%	Stats
56 (1)	Humira AbbVie Inc.	669	1.52%	Stats
57 (2)	Victoza Novo Nordisk	639	3.73%	Stats
58	Epogen Amgen Inc.	631	1.12%	Stats
59 ()	divalproex sodium Generic	615	n/a	Stats
60 (1)	Rituxan Genentech, Inc.	545	1.30%	Stats
61 (1)	Truvada Gilead Sciences, Inc.	532	-0.56%	Stats
62 (1)	Avastin Genentech, Inc.	455	0.22%	Stats
63 (3)	Atripla Gilead Sciences, Inc.	428	-0.23%	Stats
64 (3)	Viagra	398	-1.00%	Stats
65 (1)	Rebif EMD Serono, Inc.	395	-12.61%	Stats
66 (2)	Seroquel XR AstraZeneca	378	0.80%	Stats
67 (2)	Renvela Sanofi	376	11.90%	Stats
68 (4)	Sensipar Amgen Inc.	339	10.78%	Stats
69 (2)	Orencia Bristol-Myers Squibb Company	328	0.31%	Stats
70	Neulasta Amgen Inc.	308	-6.10%	Stats
71 (3)	Xolair	293	-1.68%	Stats
72 (1)	Lunesta Sunovion Pharmaceuticals Inc.	284	-6.58%	Stats
73 (4)	Adderall XR Takeda Pharmaceutical Company Limited	282	1.81%	Stats
74 (4)	Lucentis Genentech, Inc.	275	0.36%	Stats
75 (5)	Prezista Janssen Pharmaceuticals, Inc.	266	3.10%	Stats
76 (3)	Isentress Merck	263	-0.38%	Stats
77 (2)	Procrit Janssen Pharmaceuticals, Inc.	261	-10.00%	Stats
78 (4)	Reyataz Bristol-Myers Squibb Company	231	-2.53%	Stats
79 (2)	Aranesp Amgen Inc.	217	-11.43%	Stats
80 (4)	Alimta Eli Lilly and Company	204	7.94%	Stats
81 (2)	Copaxone Teva Pharmaceuticals USA, Inc.	202	-5.16%	Stats
82 (7)	Zostavax Merck	182	20.53%	Stats
83 (2)	Prevnar 13 Pfizer Inc.	180	6.51%	Stats
84 (4)	Invega Sustenna Janssen Pharmaceuticals, Inc.	170	9.68%	Stats
85 (1)	Herceptin Genentech, Inc.	167	3.09%	Stats
86 ()	Synagis MedImmune, Inc.	157	n/a	Stats
87	Neupogen Amgen Inc.	147	-5.77%	Stats
88 (2)	Xgeva Amgen Inc.	134	3.08%	Stats
89 (2)	Betaseron Bayer HealthCare Pharmaceuticals Inc.	116	-3.33%	Stats
90 (2)	Tecfidera Biogen Inc.	113	16.49%	Stats
91 ()	Complera Gilead Sciences, Inc.	107	n/a	Stats
92 ()	Stribild Gilead Sciences, Inc.	99	n/a	Stats
93	Gleevec Novartis Pharmaceuticals Corporation	81	3.85%	Stats
94	Avonex Biogen Inc.	70	-6.67%	Stats
95	Gilenya Novartis Pharmaceuticals Corporation	64	4.92%	Stats
96	Xeloda Genentech, Inc.	60	1.69%	Stats
97	Avonex Pen Biogen Inc.	52	8.33%	Stats
98	Zytiga Janssen Pharmaceuticals, Inc.	36	5.88%	Stats
99	Stelara Janssen Pharmaceuticals, Inc.	30	11.11%	Stats
100	Afinitor Novartis Pharmaceuticals Corporation	24	n/a	Stats